BioSpace News Archive

Business

Innovus Pharma Expands International Distribution by Signing an Exclusive Agreement in Peru with Pharma Solutions for Zestra, Zestra Glide, EjectDelay and Sensum+

The Company expects to ship its first commercial order to Peru within thirty (30) days of Pharma Solutions receiving regulatory approval from the Peru Health Authorities, which is currently expected to be Q1 2018.

December 1, 2017

·

8 min read

Policy

Lannett Announces FDA Acceptance of 505(b)(2) NDA for Cocaine Hydrochloride Topical Solution, a Proprietary Anesthetic Product

Lannett Company today announced that the 505(b)(2) NDA for Cocaine Hydrochloride (HCl) Topical Solution, 4% and 10%, with a proposed trade name of Numbrino, has been accepted for filing with standard review by the FDA.

December 1, 2017

·

3 min read

Business

Aerie Pharmaceuticals Announces Appointment of Paul Bae as Vice President of Human Resources

Mr. Bae will be responsible for leading the strategic human resources effort to recruit, develop and retain employees in the U.S., with an initial focus on further building Aerie’s commercial team.

December 1, 2017

·

5 min read

Business

Corindus Partners With Houston Methodist DeBakey Heart & Vascular Center to Launch Premier Robotic Training Site for Physicians

Houston Methodist DeBakey Heart & Vascular Center has launched the first vascular robotic program in the Houston area with the installation of two CorPath® GRX Systems.

December 1, 2017

·

6 min read

Prometic Announces the Closing of its $80M Line of Credit With Structured Alpha LP, an Affiliate of Thomvest Asset Management

As partial consideration for establishing the Credit Facility, Prometic has granted Structured Alpha LP an initial 10 million warrants with an exercise price of CAD $1.70 per common share with a term expiring June 30, 2026.

December 1, 2017

·

4 min read

Concordia Announces Receipt of Nasdaq Initial Notice of Bid Price Requirement

The Company’s common shares traded below a bid price of US$1.00 for 30 consecutive business days from October 17, 2017, to November 28, 2017.

December 1, 2017

·

5 min read

Business

RXi Pharma and the Center for Cancer Immune Therapy at Herlev Hospital Announce Research Collaboration

RXi Pharma today announced that they have entered into a collaborative research agreement to evaluate the potential of RXi’s novel sd-rxRNA technology platform in TILs for the use in treatment for a number of cancer types, including melanoma and ovarian cancer.

December 1, 2017

·

5 min read

Biotech Beach

Nihon Kohden Backs Epilepsy Research

For the ninth consecutive year, Nihon Kohden has donated the proceeds from the sale of one of its EEG-1200A machines to benefit the American Epilepsy Society’s clinical and basic research fellowships.

December 1, 2017

·

2 min read

Policy

Aradigm Announces FDA Advisory Committee Meeting for Linhaliq

Aradigm Corporation announced that a meeting of the Antimicrobial Drugs Advisory Committee of the FDA has been scheduled for January 11, 2018 to review the Company’s New Drug Application (NDA) for Linhaliq.

December 1, 2017

·

3 min read

Novocure Receives Reimbursement Approval for Optune in Japan for the Treatment of Newly Diagnosed Glioblastoma

Optune is a noninvasive, portable device approved in Japan to treat newly diagnosed and recurrent GBM.

December 1, 2017

·

7 min read